Despite TELA Bio's high revenue growth, its P/S ratio barely...

Moomoo AI Oct 9, 2023 19:45

Despite TELA Bio's high revenue growth, its P/S ratio barely aligns with industry median, indicating public skepticism about future growth. Its current stock price could be attractive, yet it shows two risk signs.

Market Cool On TELA Bio, Inc.'s (NASDAQ:TELA) Revenues Pushing Shares 25% Lower

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

4356 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4554Followers

0Following

9950Visitors